Free shipping on all orders over $ 500

 About 9 results found for searched term "Thromboxane B2" (0.127 seconds)

Cat.No.  Name Target
M39793 Thromboxane B2 Others
Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation.
M42383 11-Dehydro-thromboxane B2 Metabolite/Endogenous Metabolite
11-Dehydro-thromboxane B2 is a platelet hemagglutinin.
M3089 Triflusal COX
Triflusal irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1.
M4444 2,3,5,4-tetrahydroxyl-diphenylethylene-2-o-glucoside Others
2,3,4',5-Tetrahydroxystilbene 2-O-D-glucoside
2,3,4', 5-Tetrahydroxystilbene 2-O-D-glucoside was isolated from the roots of polygonum species and inhibited the formation of 5-Hete, HHT and Thromboxane B2.
M7095 Ozagrel hydrochloride Others
Ozagrel hydrochloride is a selective thromboxane A 2 synthetase inhibitor.
M7769 Daltroban Others
Selective thromboxane A2 receptor antagonist.
M18309 p-Hydroxy-cinnamic acid Metabolite/Endogenous Metabolite
p-Hydroxy-cinnamic acid inhibits platelet activity, with IC50s of 371 μM, 126 μM for thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 generation, respectively.
M29143 NTP42  Prostaglandin Receptor
NTP42 is a thromboxane A2 (TXA2) receptor antagonist with an IC50 of 3.278 nM for antagonizing T prostanoid receptor (TP)- mediated [Ca2+] mobilization following stimulation of cells with the alternative TP agonist U46619. NTP42 can be used for the treatment of pulmonary arterial hypertension (PAH).
M30263 NP-313  Thrombopoietin/Thrombin
NP-313 is a potent antithrombotic agent that inhibits platelet aggregation and activation. NP-313 has dual inhibition of thromboxane A 2 synthesis and selective inhibition of SOCC-mediated Ca2+ inward flow.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.